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     Endometriosis is considered as a multifactorial disease that affects up to 10% of all women of fertile age. 
Vascular endothelial growth factor (VEGF) is one of the most important activators of angiogenesis. VEGF 
is known to be a key molecule in the pathogenesis of endometriosis. A great number of studies have 
referred to genetic polymorphisms as a factor that contributes to the development of endometriosis. The 
present study was aimed to find out the frequency of the VEGF -1154G/A polymorphism and its 
relationship with endometriosis risk in Iranian women with endometriosis.This study involved 175 patients 
with endometriosis and 131 healthy controls. Following extraction of genomic DNA from patients and 
controls, genotyping of the -1154G/A polymorphism of the VEGF gene were performed by polymerase 
chain reaction (PCR) and restriction fragment length polymorphism (RFLP) analysis. Multivariate analysis 
was used to examine the association between the risk of endometriosis and VEGF -1154G/A 
polymorphism. There was statistically a significant difference in the frequency of the -1154G/A 
polymorphism between patients and the controls. The percentage distribution of the three -1154G/A 
genotypes was (GG 3.4%, GA %46.8%, AA 49.7%) in endometriosis patients. 
Conclusion: Data supports the hypothesis that angiogenesis is of pivotal importance in the development of 
endometriosis. Our study indicates that there is significant association between the VEGF gene -1154G/A 
polymorphism and the risk of endometriosis in North West of Iran. 
 
Keywords: Endometriosis; vascular endothelial growth factor; genetic polymorphisms 
 
INTRODUCTION 
      Endometriosis is a gynecological disease 
defined as the presence of endometrial-like 
glands and/or stroma outside the uterus. There is 
no known cause for endometriosis. Some experts 
have come up with a few possibilities, but 
nothing has been conclusively proven [1-3]. 
Many genetic studies were carried out to inspect 
the contribution of encoded genes whereas 
various studies exposed the association between 
different genotypes and the disease vulnerability 
[3-5].The most common areas for endometriosis 
to implant are on the ovaries, the outside wall of 
the uterus, fallopian tubes, pelvic cavity, 
and reproductive organ ligaments. In 
endometriosis, neovascularization is essential for 
the implantation of endometrial cells in ectopic 
sites [1-5]. Vascular endothelial growth factor 
(VEGF), known as vascular permeability factor, 
is a heparin-binding glycoprotein, playing a 
critical role in angiogenesis. VEGF is strongly 
expressed by epidermal keratinocytes in wound 
healing and psoriasis, conditions that are 
characterized by increased microvascular 
permeability and angiogenesis [4-7]. Some 
investigators have suggested higher peritoneal 
 




concentrations of VEGF in women with advanced 
stage endometriosis, and others have shown 
increased VEGF mRNA and protein expression 
in the eutopic endometrium from subjects with 
endometriosis [5-8]. 
The VEGF gene is located at 6p21.343, 
comprises a 14-kb coding region with 8 exons 
and 7 introns, which is responsible for forming 
several proteins [6-8]. Several association studies 
on single nucleotide polymorphisms (SNPs) were 
described in this gene. Moreover, association has 
been reported between endometriosis and the 
VEGF 5′-untranslated region (UTR) [+405G>C 
(rs2010963)] or 3′-UTR [+936C>T (rs3025039)] 
polymorphisms, where polymorphisms in the 
promoter region [loci −2578C>A (rs699947) and 
−460T>C (rs833061)] might alter VEGF 
expression [6-10]. VEGF is also regulated at the 
level of mRNA stability. The T allele (–460T>C 
polymorphism) may be associated with decreased 
VEGF promoter activity. The C allele of the 
+405G>C polymorphism has been associated 
with lower VEGF levels as well [7, 9]. The 
present study was designed to explore the 
association between the VEGF -1154G/A 
(rs1570360) gene polymorphism and the risk of 
advanced endometriosis in Iranian Azeri 
population. We investigated the frequency of -
1154G/A polymorphism in patients with and 
without advanced endometriosis. 
 
MATERIALS AND METHODS 
Subjects 
     From August 2014 to June 2015, all 
individuals involved in this comparative case and 
control study gave written informed consents for 
the genetic analysis. This study was approved by 
the ethic committee of Tabriz University of 
medical sciences as a research project. 
All Controls were of Iranian and selected from 
women who self-reported as never being 
diagnosed with any pelvic findings of 
endometriosis, inflammatory disease or uterine 
fibroid, and were therefore considered to be at 
low risk of having endometriosis. The diagnosis 
of endometriosis was confirmed by laparoscopy 
and classified by histological criteria according to 
the Revised American Society for Reproductive 
Medicine. Only patients with stages 1 and 2 
endometriosis have been included in this study. 
Patients who received endocrine therapy prior to 
surgery were excluded from this study. The 
characteristics of the samples are shown in Table 
1.  
Table 1. Characteristics of the samples 
 
Genomic DNA analysis 
     Peripheral blood was drawn from each patient 
and collected in an EDTA containing tube. DNA 
concentrations were quantified with a 
spectrophotometer [11]. Purified genomic DNA 
was maintained at a temperature of −20°C until 
the appearance of PCR reactions. Genotyping of 
the VEGF gene polymorphisms were performed 
by PCR and restriction fragment length 
polymorphism (RFLP) analysis, as previously 
described by Liu Qing, et al (2009) for the -
1154G/A (rs1570360) polymorphism, with minor 
modifications [10]. PCR products were digested 
with restriction enzyme MnII (New Englands 
Biolabs) for -1154G/A. The digested products 
were analyzed on 3% agarose gels stained with 
ethidium bromide. The sequence of used primers 
is presented is Table 2. 
 
 Table 2. PCR conditions for identifying VEGF -1154G/A 









Maternal age (years) 
(range, mean) 
18–44 (28.8) 19–41 (30) 





Length of menstrual 
cycle (days) (range, 
mean) 
25–30 (27.5) 27–33 (28.7) 






















206 bp MnII 
 





     Statistical analysis was performed with the 
Statistical Package for the Social Sciences 
(SPSS), version 9.0. Alleles and genotypes 
frequencies were compared between groups using 




     The age of the patients ranged from 22 to 37 
years. Chi-square (χ2) test was used to evaluate 
each allele and genotype frequency of -1154G/A 
polymorphism among the cases and controls. 
There was no significant difference in terms of 
distribution of age between the cases and controls 
(P = 0.02). Endometriosis symptoms were also 
reported by undiagnosed women. We have 
evaluated the genotypes data of 175 
endometriosis patients and 131 healthy 
individuals by PCR-RFLP. The distribution of the 
-1154G/A genotype, and the genotype specific 
ORs for patients with endometriosis and controls 
are shown in Table 3. The percentage distribution 
of the three -1154G/A genotypes GG, GA and 
AA in endometriosis patients was 3.4, 46.8 and 
49.7%, respectively, whereas, in the control 
group these frequencies were 10.7, 51.1, and 
38.2%, respectively. There was a significant trend 
between G/A genotype and higher stage of 
endometriosis (P <0.01). 
 
Table 3. Genotype and allele distributions of VEGF -1154 
G/A in Iranian Azeri women with endometriosis (n 175) and 
controls (n 131) and their association with the risk of 
developing endometriosis 
DISCUSSION 
     Genetic studies in endometriosis have been 
reviewed by several groups, showing that 
published studies are often conflicting due to 
small sample size in many studies. Previous 
studies have shown that the increased production 
of VEGF in females with endometriosis and 
increased VEGF levels have been demonstrated 
in the peritoneal tissue and blood plasma and 
peritoneal fluid of females with endometriosis [3-
6].  In order to determine a genetic predisposition 
to endometriosis, some studies were developed to 
investigate polymorphisms of the VEGF gene in 
women with endometriosis. These studies were 
conducted in China [12-13], Korea [14, 15], India 
(16), Japan [17], Turkey [18], Italy [19], and 
Spain [20]. Lee and Ho reported that VEGF in 
endometriosis significantly inhibits sperm 
motility, acrosome reaction and sperm-oocyte 
interaction, which may result in endometriosis 
associated infertility [21]. 
The VEGF gene is located at 6p21.3, at least 30 
SNPs were described in this gene. The -1154 G/A 
polymorphism of the VEGF gene was assessed by 
Liu et al. [13] and by Lamp et al. [22]. They 
studies have shown -1154A allele may be 
protective against the development of 
endometriosis in North Chinese women [13]. 
Studies by the same group of researchers showed 
that VEGF -1154G/A polymorphism was 
associated with susceptibility to endometriosis 
and adenomyosis, and the GG genotype was 
associated with high risk for the disease [23]. 
Different alleles of the -2578 C/A SNP were 
associated with reduced risk for endometriosis. 
The A allele of this polymorphism was reported 
to be protective in relation to the development of 
endometriosis [13]; This polymorphism was not 
associated with endometriosis in a study by Zhao 
et al [24]. The study by Zhao et al which assessed  
VEGF +936 C/T and -2578 A/C SNPs, was the 
only study that did not associate these SNPs with 
endometriosis [24]. It has therefore become an 
important goal to illuminate the pathogenesis of 
infertility and explore the newly identified genes 
related to endometriosis.  Based on the above 
research, it was assumed that VEGF 
polymorphisms might indeed play a certain role 
in endometriosis. The present study applied this 















































polymorphism in endometriosis development. To 
the best of the researchers' knowledge, this is the 
first study on Iranian women to examine the 
association of VEGF -1154G/A polymorphism 
with endometriosis. Data, support the hypothesis 
that angiogenesis is of pivotal importance in the 
development of endometriosis. Since genetic 
polymorphisms are different among different 
ethnic groups, the different results in different 
populations may be due to different genetic 
background. Therefore, further studies are needed 
to clarify whether the association between genetic 
polymorphisms and pregnancy outcome can be 
modified by VEGF polymorphism.  
In conclusion, this pilot study which was carried 
out in Iran focused on 175 women with 
endometriosis. A strong association between 
VEGF -1154G/A polymorphism and 
endometriosis was confirmed. The findings of the 
present study indicate that there is significant 
association between the VEGF gene -1154G/A 
polymorphism and the risk of endometriosis.  
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